Biogen Inc

NASDAQ:BIIB   3:59:59 PM EDT
331.71
+4.98 (+1.52%)
4:00:00 PM EDT: $331.70 -0.01 (0.00%)
Products

Eisai, Biogen Says U.S. FDA Grants Breakthrough Therapy Designation For Lecanemab

Published: 06/23/2021 20:22 GMT
Biogen Inc (BIIB) - Eisai and Biogen Announce U.S. FDA Grants Breakthrough Therapy Designation for Lecanemab, for the Treatment of Alzheimer’s Disease.